Viewing nowNelfra 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Korea Nelson Pharmaceutical Co., Ltd.

MFDS item code 201700947 · Approved 2017.02.22 · Insurance code 656701990
Treatment of reflux disease and Zollinger-Ellison syndrome; Helicobacter pylori eradication; treatment and prevention of gastrointestinal symptoms and ulcers
This medication can be used long-term for the treatment and prevention of gastroesophageal reflux disease, especially erosive esophagitis. It is also effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used as part of combination therapy with antibiotics for treating duodenal ulcers or peptic ulcers due to Helicobacter pylori infection, helping to prevent recurrence. It is also suitable for short-term therapy related to upper gastrointestinal symptoms that may occur from using non-steroidal anti-inflammatory drugs. For patients requiring continuous use of non-steroidal anti-inflammatory drugs, it helps treat and prevent gastric ulcers and duodenal ulcers. Additionally, it is used for the treatment of Zollinger-Ellison syndrome and as maintenance therapy to prevent rebleeding from gastric or duodenal ulcers. Overall, it is used in the treatment and prevention of various gastrointestinal disorders.
Swallow this medicine with liquid such as water; do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for controlling recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following intravenous induction to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this medicine. 6. Older adults No dose adjustment is necessary.
Adolescents 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for controlling recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years - There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to patients who have allergic reactions or hypersensitivity to specific ingredients. In particular, patients who are allergic to penicillins, macrolide antibiotics, those taking specific heart-related medications, and nursing women should avoid using this medication. This medication contains Yellow No. 5 (Tartrazine), and patients with allergies to this component should be cautious. During use, various side effects such as headache, dizziness, abdominal pain, diarrhea, and skin rash may occur, so if any abnormal symptoms appear, immediate consultation with a doctor is necessary. Especially, if symptoms such as muscle pain, weakness, or arrhythmias occur, stop taking the medication immediately and seek medical evaluation. This medication can lower gastric acidity, increasing the risk of bacterial infections, so if diarrhea persists or worsens, inform healthcare providers. Long-term use may increase the risk of bone fractures, so patients at risk for osteoporosis should undergo regular examinations. Additionally, this medication can lower serum magnesium levels, so patients using it long-term or in combination with certain diuretics should periodically check their magnesium levels. The safety of this medication during pregnancy has not been sufficiently confirmed, so pregnant women should consult a doctor before use. Nursing women are advised not to take this medication. In case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, and it should be stored out of reach of children. Furthermore, this medication may interact with various drugs, so it is essential to inform medical professionals if other medications are being taken. Regular monitoring of symptoms and test results is important while taking this medication, and immediate consultation with professionals is necessary if any unusual symptoms occur.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, jaundice, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, hyperhidrosis, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, erythema, hypertension, tachycardia, thyroid swelling, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal developmental disorder, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, elevated ALT, elevated AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening depression, excessive muscle tone, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal strictures, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is important to maintain storage temperature between 1 degree and 30 degrees Celsius to ensure the medication's effectiveness.
Pale pink rectangular film-coated tablet
28 tablets (14 tablets/Alu-Alux2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Korea Nelson Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.